Evidence map›Paper›PMID 33433033›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2021

Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.

Stylianos Ravanidis, Anastasia Bougea, Dimitra Karampatsi, Nikolaos Papagiannakis, Matina Maniati, Leonidas Stefanis, Epaminondas Doxakis

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Epigenetic mechanisms of Parkinson's disease and potential epigenetic-based therapeutics.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. The Internal Ribosome Entry Site in Circular RNAs.Advances in experimental medicine and biology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Circulating blood circular RNA in Parkinson's Disease; a systematic study.medRxiv : the preprint server for health sciences · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Stylianos RavanidisCenter of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.ORCID 0000-0002-8347-218X
Anastasia BougeaCenter of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.ORCID 0000-0003-3006-8711
Dimitra KarampatsiCenter of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Nikolaos PapagiannakisCenter of Clinical Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.ORCID 0000-0002-8401-8472
Matina ManiatiCenter of Clinical Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Leonidas StefanisCenter of Clinical Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.ORCID 0000-0003-3569-8990
Epaminondas DoxakisCenter of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.ORCID 0000-0003-1305-0739
Biomedical Research Foundation of the Academy of Athens · GRNational and Kapodistrian University of Athens · GRAcademy of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew noninvasive and affordable molecular approaches that will complement current practices and increase the accuracy of Parkinson's disease (PD) diagnosis are urgently needed. Circular RNAs (circRNAs) are stable noncoding RNAs that accumulate with aging in neurons and are increasingly shown to regulate all aspects of neuronal development and function.

objectivesΤhe aims of this study were to identify differentially expressed circRNAs in blood mononuclear cells of patients with idiopathic PD and explore the competing endogenous RNA networks affected.

methodsEighty-seven circRNAs were initially selected based on relatively high gene expression in the human brain. More than half of these were readily detectable in blood mononuclear cells using real-time reverse transcription-polymerase chain reaction. Comparative expression analysis was then performed in blood mononuclear cells from 60 control subjects and 60 idiopathic subjects with PD.

resultsSix circRNAs were significantly down-regulated in patients with PD. The classifier that best distinguished PD consisted of four circRNAs with an area under the curve of 0.84. Cross-linking immunoprecipitation-sequencing data revealed that the RNA-binding proteins bound by most of the deregulated circRNAs include the neurodegeneration-associated FUS, TDP43, FMR1, and ATXN2. MicroRNAs predicted to be sequestered by most deregulated circRNAs have the Gene Ontology categories "protein modification" and "transcription factor activity" mostly enriched.

conclusionsThis is the first study that identifies specific circRNAs that may serve as diagnostic biomarkers for PD. Because they are highly expressed in the brain and are derived from genes with essential brain functions, they may also hint on the PD pathways affected. © 2021 Biomedical Research Foundation, Academy of Athens. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Parkinson DiseaseRNA, CircularGene OntologyHumansLeukocytes, MononuclearMicroRNAsMicroRNAsRNA, CircularbiomarkersbloodcircRNAsParkinson's diseasePBMCs

Identifiers

PMID33433033
PMCPMC8248110
OpenAlexW3119420631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.